Mono Pharmacare has announced a board meeting to approve the financial results for the quarter and half-year.

Their audited consolidated results show combined assets of Rs. 52.5 Cr, revenues of Rs. 100.47 Cr, and net profit after tax of Rs. 1.57 Cr for the year.

IPO proceeds of Rs. 14.84 Cr have been fully utilized across working capital, corporate purposes, and issue expenses.

No new operational updates or business developments were reported.